DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Robert C, Grob JJ, Stroyakovskiy D. et al
Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma.
N Engl J Med 2019;
381 (07) 626-636
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.